| Cite this article: |
| DENG Yanting,XIE Zhuohua,DENG Jiasheng,FANG Yibin,ZHANG Xinru,CHEN Jeiyi,YE Xiaoxue,ZHOU Zhipin.Progress in the application of transcriptomics and metabolomics in the study of traditional Chinese medicine prevention and treatment of liver fibrosis[J].Journal Of Pharmaceutical Research,2026,45(5):562-569,595[Click to copy] |
|
| 摘要: |
| 肝纤维化是慢性肝病进展至肝硬化和肝癌的关键可逆阶段,而当前临床治疗手段仍然十分有限。中医药凭借其多成分、多靶点、整体调节的特点,在防治肝纤维化方面显示出巨大潜力,然而其复杂的作用机制尚不明确。近年来,转录组学、代谢组学技术的发展,为揭示中药多靶点作用机制提供了不同视角,其全面性、整体性和系统性特点,与中医药的“整体思想”“辨证论治”契合,弥补了单个靶点、通路解释中药“整体调控”的局限性。本文综述了转录组学、代谢组学及联合应用在中药防治肝纤维化中的应用,以期为中药抗肝纤维化的研究与新药研发提供理论依据和新的策略。 |
| 关键词: 转录组学 代谢组学 中药 肝纤维化 研究进展 |
| DOI:10.13506/j.cnki.jpr.2026.05.012 |
| 基金项目:广西中医药管理局自筹经费科研课题项目(No.GXZYB20230522) |
|
Received Date:July 29, 2025
Revision Date:September 26, 2025
Publication Date:May 29, 2026
|
|
| Progress in the application of transcriptomics and metabolomics in the study of traditional Chinese medicine prevention and treatment of liver fibrosis |
| DENG Yanting1,XIE Zhuohua1,DENG Jiasheng1,FANG Yibin2,ZHANG Xinru2,CHEN Jeiyi2,YE Xiaoxue3,ZHOU Zhipin3 |
| (1. Pharmaceutical College, Guangxi University of Chinese Medicine, Nanning 530001, China; 2. Pharmaceutical College, Guangxi Medical University, Nanning 530021, China; 3. Liuzhou People′s Hospital Affiliated to Guangxi Medical University, Liuzhou 545006, China) |
| Abstract: |
| Liver fibrosis is a critical reversible stage in the progression of chronic liver disease to cirrhosis and liver cancer, yet current clinical treatment options remain highly limited. Traditional Chinese medicine (TCM), with its multi-component, multi-target, and holistic regulatory characteristics, has demonstrated significant potential in preventing and treating liver fibrosis. However, its complex mechanisms of action are still not fully understood. In recent years, advances in transcriptomics and metabolomics have provided new perspectives for elucidating the multi-target mechanisms of TCM. The comprehensive, holistic, and systematic nature of these omics technologies aligns with the “holistic philosophy” and “treatment based on syndrome differentiation” principles of TCM, thereby overcoming the limitations of single-target or single-pathway explanations for the “overall regulation” of TCM. This review summarizes the applications of transcriptomics, metabolomics, and their integrated use in TCM for the prevention and treatment of liver fibrosis, aiming to provide a theoretical basis and novel strategies for research and drug development in this field. |
| Key words: Transcriptomics Metabolomics Traditional Chinese medicine Liver fibrosis Research progress |